Unexpected expression of carbonic anhydrase I and selenium-binding protein as the only major non-heme proteins in erythrocytes of the subterranean mole rat (Spalax ehrenbergi)  by Yang, Hong et al.
Unexpected expression of carbonic anhydrase I and selenium-binding
protein as the only major non-heme proteins in erythrocytes of the
subterranean mole rat (Spalax ehrenbergi)
Hong Yanga, Eviatar Nevob, Richard E. Tashiana;*
aDepartment of Human Genetics, University of Michigan Medical School, Medical Science II M4708, Ann Arbor, MI 48109, USA
bInstitute of Evolution, University of Haifa, Mt. Carmel, Haifa 31905, Israel
Received 27 May 1998
Abstract Chromatographic separation of the non-heme proteins
from the erythrocytes of the subterranean mole rat belonging to
the superspecies Spalax ehrenbergi from Israel revealed two
major peaks. On sequence analyses, the larger peak corre-
sponded to a 56 kDa selenium-binding protein (SeBP) previously
characterized from mouse and human liver, and the second peak
to the low-activity carbonic anhydrase (CA) isozyme, CA I.
There was no evidence of the high-activity CA II isozyme
normally found in the red cells of all amniotes tested to date.
Thus, the mole rat appears to be the first mammalian species to
express both a SeBP and the low-activity CA I isozyme, as the
major non-heme proteins in its red blood cells. It is possible that
the absence of the high-activity CA II isozyme may be
advantageous to the mole rat in adapting to the low O2 and
high CO2 environment of its underground burrows. It is also
likely that the 56 kDa SeBP may play an important adaptive role
in the physiology of the red cell.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The subterranean, blind mole rat superspecies Spalax ehren-
bergi (family Spalacidae) from the eastern Mediterranean is a
rodent that maintains high metabolic rates in adapting to the
low oxygen (6^15%) and high carbon dioxide (5^13%) atmos-
phere of its burrows [1^4]. Because of their adaptation to an
underground life, mole rats have been used as a model species
to study the physiological adjustment of mammals to a low
O2 (hypoxic) and high CO2 (hypercapnic) environment [4].
However, despite the documentation of various physiological
mechanisms that these animals seem to have evolved for
adapting to a subterranean environment [2,4^12], only a few
physicochemical aspects between mole rat and non-burrowing
rodents have been studied in an e¡ort to explain the under-
lying molecular mechanisms that may be responsible (cf.
[8,12]). Comparisons of the hemoglobins between mole rats
and white rats showed no major di¡erences that might ac-
count for their adaptation to a hypoxic environment [8]. To
our knowledge, no non-heme red cell proteins (NHP) have as
yet been examined. Because red cell carbonic anhydrase plays
such a pivotal role in acid-base balance and the transport and
conversion of CO2 (CO2+H2OIHCO33 +H
), we decided to
examine the carbonic anhydrases (CAs) of mole rat erythro-
cytes. Here, we report the surprising ¢ndings of the low-ac-
tivity carbonic anhydrase isozyme, CA I, and a 56 kDa sele-
nium-binding protein (SeBP) as the major NHPs of mole rat
red blood cells. This appears to be the ¢rst report of a mam-
malian species whose red cells contain a selenium-binding
protein as its major NHP, and CA I as its only carbonic
anhydrase isozyme.
2. Materials and methods
2.1. Blood preparation
Whole blood samples were collected from ¢ve individual mole rats
belonging to di¡erent populations across Israel (see [13] for map). Of
the ¢ve mole rat populations, two (Kerem Ben Zima and Dalton)
have the same chromosome number (2n = 52), whereas the rest possess
di¡erent chromosome numbers (i.e. Quneitra, 2n = 54; Mukhraka,
2n = 58; Lahav, 2n = 60). After centrifugation of the uncoagulated
blood, the packed red cells were washed with 0.85% NaCl, lysed
with one volume of distilled H2O, treated with toluene to remove
stromata, and the hemoglobin removed with the ethanol/chloroform
method as previously described [14^16]. The NHPs were concentrated
in dialysis tubing under vacuum. Blood from a healthy white labora-
tory rat (Rattus norvegicus) was used as a control in our experimental
procedures.
2.2. Electrophoresis
Proteins were separated in 12% vertical starch gels [14], and the
cyanogen bromide (CNBr)-digested fragments separated in 10%
SDS-PAGE gels. CA activity was detected in starch gels after electro-
phoresis using the bromothymol blue staining method, and the gels
were further stained for proteins with 0.1% nigrosin [14,17].
2.3. Immunodi¡usion analysis
Antibodies were prepared in rabbits against CA I and CA II puri-
¢ed from laboratory white rat red cells, and the mole rat NHPs tested
against anti-rat CA I and CA II sera by immunodi¡usion analyses on
0.4% agar plates with appropriate controls as previously described
[17].
2.4. Chromatography
Reverse-phase high performance liquid chromatography (HPLC)
was used to separate and then to quantify the NHPs. Standard bu¡er
A (0.1% TFA) and bu¡er B (80% MeCN/0.1% TFA) were used in a
130 ABI HPLC apparatus to develop a 45^75% gradient over a re-
tention time of 60 min. Major peaks were collected and then digested
with 10 mg/ml CNBr in 70% TFA for 4 h.
2.5. Amino acid sequencing and phylogenetic analyses
Amino acid sequences from selected CNBr fragments were deter-
mined using an automatic protein sequencer (494 ABI). A BLAST
search for these sequences was conducted against existing protein
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databases. Phylogenetic analyses were carried out with the MEGA
computer program [18], and phylogenetic trees constructed using
both UPGMA and neighbor-joining methods. To examine the robust-
ness of the phylogenetic groupings, bootstrap tests with 1000 replica
were performed.
2.6. Selenium assays
Packed RBCs (0.5 ml) prepared from two mole rats (Dalton and
Quneitra) were used to measure total Se in erythrocytes by graphite
furnace atomic absorption spectroscopy (GFAAS) at the laboratory
of the National Medical Services (Willow Grove, PA). The same
amount of RBCs from a laboratory white rat was used as controls.
3. Results
3.1. Immunodi¡usion and protein analyses
After hemoglobin extraction, the remaining NHPs from all
¢ve mole rat samples showed similar patterns on starch-gel
electrophoresis. Of the two major bands, only one showed CA
activity (data not shown). In SDS-PAGE gel, two major
bands were present at 30 and 55 kDa. The proteins from all
¢ve samples cross-reacted immunologically with rabbit anti-
rat CA I sera, whereas no cross-reaction with anti-rat CA II
was observed (Fig. 1).
The ¢ve samples showed similar HPLC pro¢les, revealing
two major peaks at retention times around 20 and 28 min
(Fig. 2). The protein peak at 28 min is about 1.3 times
more abundant than the protein at 20 min. CNBr digestion
of the proteins from the two major peaks collected from the
same mole rat resulted in di¡erent peptide patterns, whereas
peaks at similar retention times from di¡erent samples showed
similar patterns (Fig. 3A). The CNBr digestion patterns of the
smaller 20 min peak from di¡erent individuals resembled the
typical CA I pattern with three major fragments at 10 kDa, 25
kDa, and 30 kDa. The CNBr digestion pattern of the major
peak at 28 min resulted in several smaller peptides of 6 15
kDa, and did not resemble the digestion patterns of either CA
I or CA II from other mammalian species (H. Yang, unpub-
lished data).
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Fig. 1. Immunodi¡usion cross-reaction patterns between rabbit anti-
rat CA I and CA II sera and mole rat red cell non-heme proteins.
Note absence of cross-reactivity with anti-CA II. Antisera in center
wells : A (I = rat anti-CA I); B (II = rat anti-CA II); surrounding
wells : 1^5 = mole rats from di¡erent populations; A6 = negative con-
trol ; B6 = rat CA positive control.
Fig. 2. HPLC pro¢les from two representative mole rats from population Dalton (A) and Lahav (B), showing major peaks identi¢ed as car-
bonic anhydrase I (CA I) and 56 kDa selenium-binding protein (SeBP). The two peaks from the Lahay mole rat (B) were not sequenced.
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3.2. Carbonic anhydrase I
The amino acid sequence of a 10 kDa CNBr fragment from
the smaller 20 min HPLC peak could be readily aligned with
other CA isozyme sequences (Fig. 4A). The putative mole rat
CA I sequence, corresponding to positions 148^165 (human
CA I numbering) of other CA isozymes [19], shared three
unique amino acid residues that are characteristic of other
CA I sequences at positions 148, 154, and 155. Compared
with the mouse CA I sequence, the mole rat sequence has
substitutions at 150-Leu/Val, 151-Gln/Pro, and 156-Asn/Ser.
Phylogenetic analysis using homologous CA I, CA II, and CA
III sequences showed that the putative mole rat CA I se-
quence clustered with the CA I sequences from other species.
Both UPGMA and neighbor-joining methods (with or with-
out p-distance and Poisson correction) constantly produced
phylogenetic trees with similar topologies. Although the 18
amino acid sequence that was compared is relatively short,
when the shark CA sequence (a precursor of CA I^III) was
used as the outgroup, the three major branches leading to CA
I, CA II, and CA III clustered separately on the phylogenetic
tree with signi¢cantly high bootstrap values of 98, 97, and
100%, respectively (Fig. 4B).
3.3. Identi¢cation of selenium-binding protein
Partial amino acid sequences of CNBr peptide fragments
from each of the two HPLC protein peaks were determined
from the Dalton mole rat. Sequencing the 4 and 18 kDa
CNBr fragments from the 28 min peak produced sequences
of eight and 19 amino acids (Fig. 3A). When a BLAST search
was performed against existing protein databases, they
matched di¡erent regions of the same mouse 56 kDa sele-
nium-binding protein sequence deposited in the Swiss protein
database (SWISS-PROT: P17563). The 19 amino acid se-
quence of the mole rat showed a 100% identity between posi-
tions 308 and 326 with the mouse 56 kDa SeBP 99 (Fig. 3B).
The eight amino acid sequence obtained from the 4 kDa frag-
ment matched the same mouse 56 kDa SeBP sequence be-
tween positions 96 and 103 with one amino acid di¡erence
(Ser/Leu) at position 102 (Fig. 3B).
3.4. Red cell selenium analyses
GFAAS measurements of total Se levels in equal amounts
(0.5 ml) of packed RBCs from one laboratory rat and two
mole rat samples were: 220 Wg/l Se in rat, and only 33 and 43
Wg/l in the two mole rat samples. The mole rat levels are also
considerably lower than the values of 220 Wg/l (rat) to 950 Wg/l
(dolphin) reported from the red cells of other mammals (H.
Yang, unpublished assays).
4. Discussion
Characteristically, both a low-activity CA I and a high-ac-
tivity CA II isozyme are found in the erythrocytes of mam-
mals. An exception to this is that only the high-activity CA II
isozyme is present in the red cells of the cat family (Felidae)
and in ruminants (e.g. ox, sheep, goat, cf. [20]). In humans,
the CO2 hydration activity of CA I is about 10 times lower
than that of CA II whose turnover number of V106 s31
makes it one of the most active enzymes known [21]. As
yet, no species of amniotes (reptiles, birds, and mammals)
has been shown to lack the high-activity CA II isozyme in
their red blood cells. When both CA I and CA II are present,
the levels of CA I are usually greater than CA II. For exam-
ple, in humans CA I and CA II levels are, respectively, V13.0
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Fig. 3. A: SDS gel showing CNBr digestion of the proteins from
the two major peaks separated by HPLC in Fig. 2. 1 = Dalton peak
at 28 min; 2 = Dalton peak at 20 min; 3 = Lahav peak at 27 min;
4 = M12 protein standard. Two partial protein sequences were ob-
tained from 13 kDa and 4 kDa fragments of the Dalton peak at 28
min. The single amino acid substitution (102-S/L) is indicated by a
dot. B: Complete sequence of mouse liver 56 kDa selenium-binding
protein [35] ; portions that were matched by sequence fragments
from mole rat are marked in bold and underlined.
Fig. 4. A: Alignment of amino acid sequence of a CNBr fragment
from 20 min HPLC peak (Fig. 2A) compared with the CA I, II and
III amino acid sequences from other mammals and shark CA (cf.
[19]). Position numbers based on human CA I sequence. B: Phylo-
genetic analysis of putative mole rat CA I sequence showing a UP-
GMA tree built using the above alignment; numbers in each node
indicate 1000 replicate bootstrap values.
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and V2.0 Wg/mg Hb [17]. In rodents, however, the levels of
CA II are often about equal to, or even greater than, CA I
([22]; R.E. Tashian, unpublished).
4.1. Carbonic anhydrase I
Evidence that CA I is the only CA isozyme in the mole rat
red blood cells comes mainly from our ¢ndings that: (a) the
hemolysates cross-reacted with anti-rat CA I, but not anti-rat
CA II sera, (b) the 18 amino acid sequence of a CNBr frag-
ment from the 20 min HPLC peak shares three residues that
are unique to the CA I sequences of other mammals, but not
found in the corresponding sequences of any other CA iso-
zyme (i.e. CA II^VII) (Fig. 4A; [19]), and (c) the clustering
(after phylogenetic analyses) of a portion of the mole rat
putative CA I amino acid sequence with the corresponding
sequence CA I sequence from other species.
The ¢nding of a mammal that characteristically does not
express any red cell CA II clearly shows that CA I alone is
capable of carrying out the transport of metabolic CO2 to the
lungs via the reversible hydration of CO2IHCO33 . This fea-
ture was predicted by the ¢nding that humans and mice with
CA II de¢ciency mutations seemingly showed no adverse res-
piratory e¡ects under normal conditions [23^25]. A recent
study of respiratory acidosis in mutant CA II-de¢cient mice
showed them to have a partial respiratory compensation for
metabolic acidosis indicating a mixed respiratory and meta-
bolic acidosis due to CA II de¢ciency in red cells and pneu-
mocytes [26]. A report on comparisons of respiratory systems
between mole rats and white rats has shown that structural
di¡erences in lung and muscle of mole rats might account for
their higher O2 di¡using capacity to achieve high metabolism
underground [7]. It has also been reported that compared to
the white rat, the urine of the mole rat shows higher levels of
calcium and magnesium bicarbonate suggesting that this may
be a means for the mole rat to reduce its CO2 in a hyper-
capnic environment [12].
Why would the absence of the high-activity, CA II isozyme
in the red cells of the mole rat be advantageous? One possi-
bility is that the respiratory acidosis produced by the in-
creased CO2 in the blood stimulates more rapid breathing
thereby taking up more O2 from the hypoxic environment.
If the high-activity CA II was present, it would tend to lower
the PCO2 , thereby countering the adaptive e¡ects of the in-
creased breathing. This may also be the reason that the ad-
ministration of CA inhibitors to dogs and humans can assist
in their accommodation to high altitude [27,28]. Another ad-
vantage might be that the respiratory acidosis would produce
a left-shifted Hb-O2 dissociation curve that would facilitate
O2 release to the tissues [29^31]. A further possibility is that
the high ventilatory drive produced by the ine⁄cient removal
of CO2 would be useful in regulating body temperature when
the temperatures of the underground burrows reach high lev-
els. Obviously, critical comparative physiological experiments
under hypoxic stress must be undertaken between mole rats
and non-subterranean rodents in order to gain insights into
the physiological aspects of their adaptations. It should be
noted that the above suggestions are based on the assumption
that the mole rat CA I possesses the characteristic low activity
of CA I isozymes, and this has not yet been demonstrated.
4.2. Selenium-binding protein
In mammals, the trace element selenium (Se) is an essential
nutrient, with highest concentrations (humans) in kidney, liv-
er, and spleen. In humans and other mammals a number of
abnormalities are known to result from Se de¢ciency. Se is
also known to inhibit cell growth, and Se-supplemented diets
appear to reduce the incidence of a variety of cancers. A
number of selenoproteins, some of which are enzymes, have
been identi¢ed in mammals [32^34], ranging in molecular
weight from 10 to s 90 kDa. In mammals, these SeBPs
have been found in almost every tissue; however, as yet no
Se-BP been detected in erythrocytes, with the exception of
glutathione peroxidase which is present at very low levels
[32^34]. Thus, detection of a 56 kDa SeBP as the major
non-heme protein in the red cells of the mole rat was a rather
surprising ¢nding.
Orthologues of the 56 kDa SeBP had previously been re-
ported from human and mouse liver cDNAs [35,36]. The de-
rived proteins are 472 amino acids in length and the human
and mouse sequences are highly conserved with an identity of
87%. The total 27 amino acid residues in the two mole rat
fragments di¡ered by only one residue from the mouse se-
quence. It would thus appear that the mouse and mole rat
56 kDa SeBPs would be highly conserved which could indi-
cate an important physiological function that might involve
binding to cellular proteins or structures.
The unusually low concentration of Se that we detected in
mole rat RBCs suggests that the expression of 56 kDa SeBP in
the red cells might play a role in the tissue transport or stor-
age of Se. Since the mole rats samples were collected from
di¡erent populations with di¡erent soil types across Israel
[37], it is unlikely that the low Se and high SeBP in mole
rat RBCs simply re£ect an abnormal geochemical distribution
in the local environment. It is also conceivable that the 56
kDa SeBP may interact with hemoglobin or other RBC pro-
teins to alter O2 or CO2 binding a⁄nities.
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